CIK 0001723128
- Large accelerated filer
Amneal Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AMRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- Phone
- +1 908-947-3120
- Former names
- Atlas Holdings, Inc.
- 4 Derivatives Options or other derivatives
- 4 Conversion Director acquired 12,887,433 shares (conversion)
- 4 Open-market buy Director bought 50,000 shares at $2.39 ($119,500)
- 4 Open-market buy SVP, Chief Scientific Officer bought 30,000 shares at $2.41 ($72,300)
- 4 Open-market buy 10% owner bought 327,000 shares at $2.91 ($951,570)
- 4 Open-market buy Exec VP, Comm Optns bought 66,666 shares at $2.89 ($192,665)
- 4 Open-market buy 10% owner bought 1,642,300 shares at $3.04 ($4,992,592)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy SVP, Chief Scientific Officer bought 7,000 shares at $8.48 ($59,360)
- 4 Open-market buy Exec VP, Comm Optns bought 19,000 shares at $9.46 ($179,740)
- 4 Open-market buy SVP, Specialty Commercial bought 15,000 shares at $9.88 ($148,200)
- 4 Shares withheld for taxes SVP, Specialty Commercial gave up 2,228 shares (to pay taxes)
- 4 Shares withheld for taxes Exec VP, Comm Optns gave up 8,353 shares (to pay taxes)
- 4 Shares withheld for taxes Executive Chairman gave up 12,529 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 21,609 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Chief HR Officer gave up 1,366 shares (to pay taxes)
- 4 Exercise or conversion Director acquired 6,107 shares (option exercise)
- 4 Exercise or conversion Director acquired 6,107 shares (option exercise)
Page 14 of 18 · 351 filings